Related references
Note: Only part of the references are listed.Adoptive Transfer of JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy
Giulia Berzero et al.
ANNALS OF NEUROLOGY (2021)
Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease
Irene Cortese et al.
NATURE REVIEWS NEUROLOGY (2021)
Ibrutinib treatment of mantle cell lymphoma complicated by progressive multifocal leukoencephalopathy
Kristina Mosna et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2020)
Sequential interleukin 2 and pembrolizumab use in progressive multifocal leukoencephalopathy
Christoph Mahler et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab
Alex Holmes et al.
JOURNAL OF NEUROVIROLOGY (2020)
Infections in the Era of Targeted Therapies: Mapping the Road Ahead
Leonard H. Calabrese et al.
FRONTIERS IN MEDICINE (2020)
Prevalence of Anti-JC Virus Antibody Seropositivity in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis
Sara Hanaei et al.
INTERVIROLOGY (2020)
Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report
Yanira Ruiz-Heredia et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)
Progressive multifocal leukoencephalopathy treated with nivolumab
Ethan Hoang et al.
JOURNAL OF NEUROVIROLOGY (2019)
Immune profiling of a patient with alemtuzumab-associated progressive multifocal leukoencephalopathy
Simonetta Gerevini et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
Irene Cortese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Can Immune Checkpoint Inhibitors Keep JC Virus in Check?
Igor J. Koralnik
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab
Sebastian Rauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab
Ondine Walter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later
Pawel Robak et al.
DRUGS IN R&D (2019)
Progressive multifocal leukoencephalopathy and anti-CD20 monoclonal antibodies: What do we know after 20 years of rituximab
Daniele Focosi et al.
REVIEWS IN MEDICAL VIROLOGY (2019)
Fatal encephalopathy with wild-type JC virus and ruxolitinib therapy
Lauren Bowen Reoma et al.
ANNALS OF NEUROLOGY (2019)
Progressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemia
Vlatko Pejsa et al.
ANNALS OF HEMATOLOGY (2019)
Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency
Clemens Kuepper et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
Ineffective treatment of PML with pembrolizumab Exhausted memory T-cell subsets as a clue?
Marc Pawlitzki et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
Pembrolizumab as a treatment for PML? Waiting for Godot
Renaud A. Du Pasquier
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
Lenalidomide-related Progressive Multifocal Leukoencephalopathy: A Case Report and Review of Drug-related Cases in Multiple Myeloma
Stephanie Anderson et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
The spectrum of progressive multifocal leukoencephalopathy: a practical approach
T. Bartsch et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
Lenalidomide for the treatment of mantle cell lymphoma
Fortunato Morabito et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
The occurrence of polyomaviruses WUPyV and KIPyV among patients with severe respiratory infections
Debora Bellini Caldeira et al.
BRAZILIAN JOURNAL OF MICROBIOLOGY (2019)
Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia
Charles L. Bennett et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Progressive multifocal leukoencephalopathy during ixazomib-based chemotherapy
C. P. Sawicki et al.
CURRENT ONCOLOGY (2018)
T cell deficiencies as a common risk factor for drug associated progressive multifocal leukoencephalopathy
Dejan Pavlovic et al.
IMMUNOBIOLOGY (2018)
Ibrutinib Use Complicated by Progressive Multifocal Leukoencephalopathy
David Hsiehchen et al.
ONCOLOGY (2018)
Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy
Muharrem Muftuoglu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Systematic review of the published data on the worldwide prevalence of John Cunningham virus in patients with multiple sclerosis and neuromyelitis optica
Sonia Patricia Castedo Paz et al.
EPIDEMIOLOGY AND HEALTH (2018)
Modern multiple myeloma therapy: deep, sustained treatment response and good clinical outcomes
O. Landgren et al.
JOURNAL OF INTERNAL MEDICINE (2017)
Fatal ruxolitinib-related JC virus meningitis
Begona Ballesta et al.
JOURNAL OF NEUROVIROLOGY (2017)
Human polyomavirus 6 and 7 are associated with pruritic and dyskeratotic dermatoses
Khang D. Nguyen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Lenalidomide-associated progressive multifocal leukoencephalopathy
Francesco Brigo et al.
LEUKEMIA & LYMPHOMA (2017)
Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia
Mathias Lutz et al.
CANCER RESEARCH AND TREATMENT (2017)
Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial
Jeffrey A. Jones et al.
LANCET HAEMATOLOGY (2017)
Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review
Elizabeth C. Neil et al.
BLOOD ADVANCES (2017)
ECULIZUMAB-RELATED PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
Emilio Gomez-Cibeira et al.
NEUROLOGY (2016)
Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: case report and review of literature
Divyanshu Dubey et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2016)
Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting system
Dennis W. Raisch et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Immune suppression of JC virus gene expression is mediated by SRSF1
Rahsan Sariyer et al.
JOURNAL OF NEUROVIROLOGY (2016)
Progressive multifocal leukoencephalopathy after autologous peripheral blood stem cell transplantation in a patient with multiple myeloma treated with combination therapy
Kazuki Yokokawa et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Suppressive effect of topoisomerase inhibitors on JC polyomavirus propagation in human neuroblastoma cells
Souichi Nukuzuma et al.
MICROBIOLOGY AND IMMUNOLOGY (2016)
Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a Phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia
Carol Moreno et al.
HAEMATOLOGICA (2015)
Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a Phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia
Carol Moreno et al.
HAEMATOLOGICA (2015)
Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia
Kami J. Maddocks et al.
JAMA ONCOLOGY (2015)
Progressive Multifocal Leukoencephalopathy Associated With Brentuximab Vedotin Therapy A Report of 5 Cases from the Southern Network on Adverse Reactions (SONAR) Project
Kenneth R. Carson et al.
CANCER (2014)
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
BK and JC virus: A review
Michelle Pinto et al.
JOURNAL OF INFECTION (2014)
The human polyomavirus BK (BKPyV): virological background and clinical implications
Christine Hanssen Rinaldo et al.
APMIS (2013)
Progressive Multifocal Leukoencephalopathy Associated with Ruxolitinib
Rowan Wathes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Molecular Biology, Epidemiology, and Pathogenesis of Progressive Multifocal Leukoencephalopathy, the JC Virus-Induced Demyelinating Disease of the Human Brain
Michael W. Ferenczy et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Increased Program Cell Death-1 Expression on T Lymphocytes of Patients With Progressive Multifocal Leukoencephalopathy
Chen Sabrina Tan et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy
Serena Delbue et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Discovery of a Novel Polyomavirus in Acute Diarrheal Samples from Children
Guixia Yu et al.
PLOS ONE (2012)
Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto-SCT successfully treated with combination therapy
L. Fianchi et al.
BONE MARROW TRANSPLANTATION (2010)
Progressive Multifocal Leukoencephalopathy in Chronic Lymphocytic Leukemia: A Report of Three Cases and Review of the Literature
Anita D'Souza et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2010)
Human Polyomavirus JC (JCV) Infection of Human B Lymphocytes: A Possible Mechanism for JCV Transmigration across the Blood-Brain Barrier
Moti L. Chapagain et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
Massimo Federico et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Progressive Multifocal Leukoencephalopathy Following Heightened Immunosuppression After Lung Transplant
Jesse Waggoner et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2009)
Progressive multifocal leukoencephalopathy in a patient with relapsed acute myelogenous leukemia
Santosh Kesari et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Clonal integration of a polyomavirus in human Merkel cell carcinoma
Huichen Feng et al.
SCIENCE (2008)
Infectious complications associated with alemtuzumab use for lymphoproliferative disorders
Stanley I. Martin et al.
CLINICAL INFECTIOUS DISEASES (2006)
Follicular lymphoma international prognostic index
P Solal-Céligny et al.
BLOOD (2004)
Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children
C Polo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study
M Uppenkamp et al.
ANNALS OF HEMATOLOGY (2002)
Share Paper
